Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet
NEW YORK, June 14, 2013 /NEWS.GNOM.ES/ — The law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP has just commenced what is believed to be the first suit in New York for the development of pancreatic cancer in the user of two common anti-diabetic drugs, Byetta and Janumet (also known as Januvia). The suit, by Staten Island resident Robert Cataletto, was filed on June 14, 2013 Cataletto v. Amylin Pharmaceuticals, LLC, et al., E.D.N.Y. CV 13-3411.
Mr. Cataletto received prescriptions from the doctor attending to his adult diabetes condition in the period from 2009 to 2012 for Byetta and Janumet. Byetta, manufactured by Merck, Inc., has been on the market since 2005 and is known as a glucagen-like peptide. It treats diabetes by preventing a build- up of sugar in the body.
Junuvia is made by Amylin Pharmaceuticals LLC, a company recently bought by Bristol Myers Squibb Co. First marketed in 2007, it in the category of a dipeptidyl-peptidase-4 drug, which also reduces blood glucose levels. When combined with an older drug, metformin, the drug is known as Janumet. The broader category for the drugs involved in this law suit is known as “incretins.”
The complaint which was just filed alleges that the manufacturers of both of these products were alerted starting in 2010 that there was an increased incidence of pancreatic cancer in users of these drugs as compared to diabetics treated with the older, more proven forms of treatment. The notice also came from the German Medical Association and a petition by Public Citizen, a non-profit health group in Washington.
There have been similar reports of a sharp increase in pancreatitis—inflammation of the pancreas gland—in users of these same drugs. The complaint alleges that pancreatitis may be a forerunner of pancreatic cancer. Pancreatic cancer is among the deadliest of all cancers, for which there are no satisfactory treatments.
Complete article:
http://news.gnom.es/pr/suit-filed-for-pancreatic-cancer-by-use-of-byetta-januvia-and-janumet
Thanks for the link.